Abstract
The association between blood pressure (BP) and its variability (BPV) with psychological disorders has been established. We aimed to investigate whether this relationship extends to the risk of suicide in a large, nationally representative cohort. This retrospective cohort study included 1,983,107 participants from the Korean National Health Insurance Service database, collected between 2005 and 2009, with 11.1 years of follow-up. BPV was assessed using at least three health examination datasets and validated variability indices (variability independent of the mean [VIM], average successive variability, and coefficient of variation). The primary endpoint was suicide-related death. Cox proportional hazards models were used to estimate hazard ratios (HRs) for suicide across BPV quartiles. Higher BP and BPV were significantly associated with an increased risk of suicide. Participants in the highest quartile (Q4) of systolic BPV (VIM) had an adjusted HR of 1.13 (95% CI: 1.05–1.22) for suicide. Similarly, those in Q4 of diastolic BPV (VIM) had an HR of 1.16 (95% CI: 1.08–1.24). This association was particularly pronounced in older adults (≥65 years), with an HR of 1.18 (95% CI: 1.03–1.36) for systolic BPV and 1.21 (95% CI: 1.05–1.39) for diastolic BPV in Q4. Consistent findings were observed when using different variability indices. Subgroup analyses according to sex, diabetes, depression, hypertension, and use of antihypertensive medications also supported these findings. These findings suggest that both BP and BPV are novel risk factors for suicide mortality. Considering BP and BPV together may enhance the identification of individuals at higher risk of suicide.

This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout


Similar content being viewed by others
References
Ilic M, Ilic I. Worldwide suicide mortality trends (2000-2019): a joinpoint regression analysis. World J Psychiatry. 2022;12:1044–60.
Noh H, Seo, J, Lee, S, Yi N, Park S, Choi Y-J, et al. Cause-of-death statistics in 2020 in the Republic of Korea. J Korean Med Assoc Taehan Uisa Hyophoe Chi. 2023;66:132.
Abou Chahla MN, Khalil MI, Comai S, Brundin L, Erhardt S. Guillemin GJ. Biological factors underpinning suicidal behaviour: an update. Brain Sci. 2023;13:505.
Favril L, Yu R, Geddes JR, Fazel S. Individual-level risk factors for suicide mortality in the general population: an umbrella review. Lancet Public Health. 2023;8:e868–e77.
Sobolewska-Nowak J, Wachowska K, Nowak A, Orzechowska A, Szulc A, Płaza O, et al. Exploring the heart-mind connection: unraveling the shared pathways between depression and cardiovascular diseases. Biomedicines. 2023;11:1903.
Valenza G. Depression as a cardiovascular disorder: central-autonomic network, brain-heart axis, and vagal perspectives of low mood. Front Netw Physiol. 2023;3:1125495.
de la Sierra A. Blood pressure variability as a risk factor for cardiovascular disease: which antihypertensive agents are more effective? J Clin Med. 2023;12:6167.
Mancia G, Grassi G. The autonomic nervous system and hypertension. Circ Res. 2014;114:1804–14.
Das D, Shruthi NR, Banerjee A, Jothimani G, Duttaroy AK, Pathak S. Endothelial dysfunction, platelet hyperactivity, hypertension, and the metabolic syndrome: molecular insights and combating strategies. Front Nutr. 2023;10:1221438.
McCall WV, Rosenquist PB, Miller BJ. Development of autonomic nervous system assays as point-of-care tests to supplement clinical judgment in risk assessment for suicidal behavior: a review. Curr Psychiatry Rep. 2022;24:11–21.
Kemp AH, Quintana DS, Gray MA, Felmingham KL, Brown K, Gatt JM. Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis. Biol Psychiatry. 2010;67:1067–74.
Kim MK, Han K, Lee SH. Current trends of big data research using the Korean national health information database. Diab Metab J. 2022;46:552–63.
Lee YB, Kim H, Lee J, Kang D, Kim G, Jin SM, et al. Psychotic disorders and the risk of type 2 diabetes mellitus, atherosclerotic cardiovascular diseases, and all-cause mortality: a population-based matched cohort study. Diab Metab J. 2024;48:122–33.
WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–63.
Kim MK, Han K, Koh ES, Kim ES, Lee M-K, Nam GE, et al. Blood pressure and development of cardiovascular disease in Koreans with type 2 diabetes mellitus. Hypertension. 2019;73:319–26.
Baek JH, Park YM, Han KD, Moon MK, Choi JH, Ko SH. Comparison of operational definition of type 2 diabetes mellitus based on data from Korean National Health Insurance Service and Korea National Health and Nutrition Examination Survey. Diab Metab J. 2023;47:201–10.
Lee J, Jung J-H, Kang DW, Kim M-H, Lim D-J, Kwon H-S, et al. Body weight variability and risk of suicide mortality: a nationwide population‐based study. Depression Anxiety. 2024;2024:7670729.
Lee J, Han K, Park SH, Kim MK, Lim DJ, Yoon KH, et al. Associations of variability in body weight and glucose levels with the risk of hip fracture in people with diabetes. Metabolism. 2022;129:155135.
Kim MK, Han K, Kim HS, Park YM, Kwon HS, Yoon KH, et al. Effects of variability in blood pressure, glucose, and cholesterol concentrations, and body mass index on end-stage renal disease in the general population of Korea. J Clin Med. 2019;8:755.
Lee JM, Lee J, Lim J, Park S, Ki M, Kang J. Increased suicide risk of psychiatric patients following the recent utilization of health care services: results from a nationwide cohort study in South Korea. Front Public Health. 2023;11:1118135.
Yu J, Song Q, Bai J, Wu S, Bu P, Li Y, et al. Visit-to-visit blood pressure variability and cardiovascular outcomes in patients receiving intensive versus standard blood pressure control: insights from the STEP Trial. Hypertension. 2023;80:1507–16.
Joung KI, Cho SI. Association of low blood pressure with suicidal ideation: a cross-sectional study of 10,708 adults with normal or low blood pressure in Korea. BMC Public Health. 2018;18:200.
Sheikh AB, Sobotka PA, Garg I, Dunn JP, Minhas AMK, Shandhi MMH, et al. Blood pressure variability in clinical practice: past, present and the future. J Am Heart Assoc. 2023;12:e029297.
Johansson JK, Niiranen TJ, Puukka PJ, Jula AM. Prognostic value of the variability in home‐measured blood pressure and heart rate: the Finn‐Home Study. Hypertension. 2012;59:212–8.
Rothwell PM, Howard SC, Dolan E, O’Brien E, Dobson JE, Dahlöf B, Sever PS, Poulter NR. Prognostic significance of visit‐to‐visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375:895–905.
Zhou TL, Henry RM, Stehouwer CD, van Sloten TT, Reesink KD, Kroon AA. Blood pressure variability, arterial stiffness, and arterial remodeling: the Maastricht study. Hypertension. 2018;72:1002–10.
Wu EL, Chien IC, Lin CH, Chou YJ, Chou P. Increased risk of hypertension in patients with major depressive disorder: a population-based study. J Psychosom Res. 2012;73:169–74.
Penninx BW, Milaneschi Y, Lamers F, Vogelzangs N. Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Med. 2013;11:129.
Jani BD, Cavanagh J, Barry SJ, Der G, Sattar N, Mair FS. Revisiting the J shaped curve, exploring the association between cardiovascular risk factors and concurrent depressive symptoms in patients with cardiometabolic disease: findings from a large cross-sectional study. BMC Cardiovasc Disord. 2014;14:139.
Tully PJ, Tzourio C. Psychiatric correlates of blood pressure variability in the elderly: The three city cohort study. Physiol Behav. 2017;168:91–7.
Zhou J, Lee S, Wong WT, Leung KSK, Nam RHK, Leung PSH, et al. Gender- and age-specific associations of visit-to-visit blood pressure variability with anxiety. Front Cardiovasc Med. 2021;8:650852.
Tully PJ, Debette S, Tzourio C. The association between systolic blood pressure variability with depression, cognitive decline and white matter hyperintensities: the 3C Dijon MRI study. Psychol Med. 2018;48:1444–53.
Inoue K, Horwich T, Bhatnagar R, Bhatt K, Goldwater D, Seeman T, et al. Urinary stress hormones, hypertension, and cardiovascular events: the multi-ethnic study of atherosclerosis. Hypertension. 2021;78:1640–7.
Won E, Kim YK. Neuroinflammation-associated alterations of the brain as potential neural biomarkers in anxiety disorders. Int J Mol Sci. 2020;21:6546.
Cui L, Li S, Wang S, Wu X, Liu Y, Yu W, et al. Major depressive disorder: hypothesis, mechanism, prevention and treatment. Signal Transduct Target Ther. 2024;9:30.
Filchenko I, Mürner N, Dekkers MPJ, Baillieul S, Duss SB, Brill AK, et al. Blood pressure variability, nocturnal heart rate variability and endothelial function predict recurrent cerebro-cardiovascular events following ischemic stroke. Front Cardiovasc Med. 2023;10:1288109.
Wu Z, Zhang H, Wang Y, Li Z, Li X, Tao L, et al. Temporal and bidirectional association between blood pressure variability and arterial stiffness: cross-lagged cohort study. JMIR Public Health Surveill. 2023;9:e45324.
Sun F. The impact of blood pressure variability on cognition: current limitations and new advances. J Hypertens. 2023;41:888–905.
Mann JJ, Rizk MM. A brain-centric model of suicidal behavior. Am J Psychiatry. 2020;177:902–16.
Kim KI, Lee JH, Chang HJ, Cho YS, Youn TJ, Chung WY, et al. Association between blood pressure variability and inflammatory marker in hypertensive patients. Circ J. 2008;72:293–8.
Han KM, Ham BJ. How inflammation affects the brain in depression: a review of functional and structural MRI studies. J Clin Neurol. 2021;17:503–15.
Kouba BR, de Araujo Borba L, Borges de Souza P, Gil-Mohapel J, Rodrigues ALS. Role of inflammatory mechanisms in major depressive disorder: from etiology to potential pharmacological targets. Cells. 2024;13:423.
Almarzouki AF, Alluhaibi W, Salman B, Almuhaiyawi M, Alreemi M, Alsahafi M. The impact of cognitive functions, psychological disorders, and coping strategies on quality of life and disease outcomes in patients with inflammatory bowel diseases: a cross-sectional study. Medecine. 2024;103:e38982.
Nabi H, Chastang JF, Lefèvre T, Dugravot A, Melchior M, Marmot MG, et al. Trajectories of depressive episodes and hypertension over 24 years: the Whitehall II prospective cohort study. Hypertension. 2011;57:710–6.
Lee Y, Gilbert JR, Waldman LR, Zarate CA, Jr Ballard ED. Potential association between suicide risk, aggression, impulsivity, and the somatosensory system. Soc Cogn Affect Neurosci. 2024;19:nsae041.
Park SH, Lee YB, Lee KN, Kim B, Cho SH, Kwon SY, et al. Risk of depression according to cumulative exposure to a low-household income status in individuals with type 2 diabetes mellitus: a nationwide population- based study. Diab Metab J. 2024;48:290–301.
Amiri S, Behnezhad S. Alcohol use and risk of suicide: a systematic review and Meta-analysis. J Addict Dis. 2020;38:200–13.
Di Federico S, Filippini T, Whelton PK, Cecchini M, Iamandii I, Boriani G, et al. Alcohol intake and blood pressure levels: a dose-response meta-analysis of nonexperimental cohort studies. Hypertension. 2023;80:1961–9.
Zhang Z, Sun K, Jatchavala C, Koh J, Chia Y, Bose J, et al. Overview of stigma against psychiatric illnesses and advancements of anti-stigma activities in six asian societies. Int J Environ Res Public Health. 2019;17:280.
Acknowledgements
This study was performed using the database from the National Health Insurance System and the results do not necessarily represent the opinion of the National Health Insurance Corporation.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lee, J., Kwak, J., Jung, JH. et al. The impact of blood pressure and its variability on suicide mortality: a nationwide population-based study. Hypertens Res 48, 2173–2183 (2025). https://doi.org/10.1038/s41440-025-02244-6
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41440-025-02244-6
Keywords
This article is cited by
-
Can Japan contribute to developing research on the relation between blood pressure variability and suicide risk?
Hypertension Research (2025)


